Loading...
•
Sep 30, 2020
CVS Health Q3 2020 Earnings Report
CVS Health's diversified assets delivered strong enterprise performance, with full-year EPS and cash flow guidance raised.
Key Takeaways
CVS Health reported a 3.5% increase in total revenues to $67.1 billion, GAAP diluted earnings per share of $0.93, and adjusted EPS of $1.66. The company raised its full-year 2020 EPS and cash flow from operations guidance ranges.
Total revenues increased to $67.1 billion, up 3.5% compared to prior year.
GAAP diluted earnings per share of $0.93 and GAAP operating income of $3.2 billion.
Adjusted EPS of $1.66 and adjusted operating income of $3.6 billion.
Raised GAAP diluted EPS guidance range to $5.60 to $5.70 from $5.16 to $5.29 and Adjusted EPS guidance range to $7.35 to $7.45 from $7.14 to $7.27.
Revenue by Segment
Forward Guidance
The Company raised its full year 2020 GAAP diluted EPS guidance range to $5.60 to $5.70 from $5.16 to $5.29 and its full year 2020 Adjusted EPS guidance range to $7.35 to $7.45 from $7.14 to $7.27. The Company also raised its full year 2020 cash flow from operations guidance range to $12.75 billion to $13.25 billion from $11.0 billion to $11.5 billion.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...